Chemomab Therapeutics (CMMB) EBIT (2017 - 2026)
Chemomab Therapeutics' EBIT was $2.17 million in Q2 2026, up 5.3% from $2.06 million a year earlier and up 22.1% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) EBIT (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Chemomab Therapeutics' EBIT was $7.55 million through Jun 30, 2026, down 36.1% year-over-year; for FY2025, it was $9 million, down 35.5% from FY2024.
- EBIT has now declined for three consecutive years, with a four-year compound annual growth rate of -8.1% (FY2021 to FY2025).
- In earlier years, EBIT was $13.95 million in FY2024 (-39.3%), $22.98 million in FY2023 (-17.4%), $27.83 million in FY2022 (+121.0%) and $12.59 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBIT since Q1 2025.
- Compared with a year earlier, EBIT was higher in 1 of the last eight quarters, with an average decline of 24.6%.
- The best year-over-year quarter for EBIT over five years was Q2 2023 (growth of 6.4%); the worst was Q4 2023 (a decline of 62.1%).
- Per Business Quant data, CMMB's EBIT in the three quarters before Q2 2026 was $1.77 million (Q1 2026), $1.87 million (Q4 2025) and $1.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - | 2.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 3.87 Mn |
| Dec 31, 2023 | 2.99 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 7.68 Mn |
| Mar 31, 2023 | 8.73 Mn |
| Dec 31, 2022 | 7.88 Mn |
| Sep 30, 2022 | 7.84 Mn |
| Jun 30, 2022 | 7.21 Mn |
| Mar 31, 2022 | -5.10 Mn |
| Dec 31, 2021 | 19.92 Mn |
| Sep 30, 2021 | -2.97 Mn |
API Access
Chemomab Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();